Content
10/08/2024
Ponte Vedra Beach, FL USA
Orasis Pharmaceuticals
completed $78 million Series D Round funding. Investors include
Johnson & Johnson Innovation (lead), Arboretum Ventures (lead), Catalio Capital Management, Freepoint Capital Group, Visionary Ventures, Sequoia Capital, Maverick Ventures.
About
Orasis is reshaping vision possibilities. As agile partners to the eye care community, we see every day as an opportunity to disrupt conventional thinking in pursuit of vision without limitations. That is why we reimagined existing and well-studied molecules to create a unique prescription eye drop for presbyopia, QLOSI™.
Startup
Orasis Pharmaceuticals
https://www.orasis-pharma.com
Claim Profile
Location:
Ponte Vedra Beach, FL USA
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
